RELX PLC
RDEB.XETRA
| Exchange: | XETRA |
| Currency | Euro |
| ISIN: | GB00B2B0DG97 |
| LEI: | 549300WSX3VBUFFJOO66 |
| Fiscal Year End: | December |
| Sector: | Industrials |
| Industry: | Specialty Business Services |
| Gic Sector: | Materials |
| Gic Group: | Materials |
| Gic Industry: | Chemicals |
| Gic Sub Industry: | Specialty Chemicals |
| Description: | RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom. |
| Address: | 1-3 Strand, London, United Kingdom, WC2N 5JR |
| Website: | https://www.relx.com |
| Full Time Employees: | 36000 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 81155432448 |
| Market Capitalization Mln: | 81155.43 |
| EBITDA: | 3004000000 |
| PE Ratio: | 36.64 |
| PEG Ratio: | 2.63 |
| Book Value: | 1.72 |
| Dividend Share: | 0.6 |
| Dividend Yield: | 0.01 |
| Earnings Share: | 1.18 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.20 |
| Operating Margin TTM: | 0.30 |
| Return On Assets TTM: | 0.11 |
| Return On Equity TTM: | 0.59 |
| Revenue TTM: | 9303000064 |
| Revenue Per Share TTM: | 4.88 |
| Quarterly Revenue Growth YOY: | 0.03 |
| Gross Profit TTM: | 5508000000 |
| Diluted Eps TTM: | 1.18 |
| Quarterly Earnings Growth YOY: | 0.13 |
Valuation
| Trailing PE: | 36.64 |
| Forward PE: | 26.88 |
| Price Sales TTM: | 8.72 |
| Price Book MRQ: | 20.79 |
| Enterprise Value: | 87801163912 |
| Enterprise Value Revenue: | 7.96 |
| Enterprise Value Ebitda: | 21.40 |
Shares
| Shares Outstanding: | 1857479936 |
| Shares Float: | 1847270269 |
| Percent Insiders: | 0.42 |
| Percent Institutions: | 55.59 |
Technicals
| Beta: | 0.47 |
| 52 Week High: | 44.96 |
| 52 Week Low: | 32.90 |
| 50 Day MA: | 42.94 |
| 200 Day MA: | 41.12 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.71 |
| Forward Annual Dividend Yield: | 0.01 |
| Payout Ratio: | 0.58 |
| Ex Dividend Date: | 2024-08-01 |
Earnings
| Report Date: | 2025-04-25 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2025-02-14 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2024-10-24 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Date: | 2024-09-30 |